Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 22;63(1620):42-48.

Drugs for multiple sclerosis

No authors listed
  • PMID: 33976089
Review

Drugs for multiple sclerosis

No authors listed. Med Lett Drugs Ther. .
No abstract available

Keywords: Aubagio; Avonex; Betaseron; Copaxone; Extavia; Gilenya; Glatect; Glatopa; Kesimpta; Lemtrada; Mavenclad; Mayzent; Orevus; Plegridy; Rebif; Riabni; Rituxan; Riximyo; Ruxience; Tecfidera; Truxima; Tysabri; Vumerity; Zeposia; adverse effects; alemtuzumab; cladribine; dimethyl fumarate; diroximel; dosage; drug interactions; efficacy; fingolimod; glatiramer acetate; interferon beta; lactation; mitoxantrone; multiple sclerosis; natalizumab; ocrelizumab; ofatumumab; ozanimod; pregnancy; rituximab; safety; siponimod; teriflunomide.

PubMed Disclaimer

Similar articles

  • Ozanimod (Zeposia) for multiple sclerosis.
    [No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Aug 24;62(1605):132-134. Med Lett Drugs Ther. 2020. PMID: 32970043 Review. No abstract available.
  • Ublituximab (Briumvi) for relapsing multiple sclerosis.
    [No authors listed] [No authors listed] Med Lett Drugs Ther. 2023 Mar 6;65(1671):36-38. doi: 10.58347/tml.2023.1671c. Med Lett Drugs Ther. 2023. PMID: 36877282 No abstract available.
  • Siponimod (Mayzent)--a new drug for multiple sclerosis.
    [No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 May 6;61(1571):70-72. Med Lett Drugs Ther. 2019. PMID: 31169805 No abstract available.
  • Cladribine (Mavenclad) for multiple sclerosis.
    [No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Jul 29;61(1577):118-120. Med Lett Drugs Ther. 2019. PMID: 31381552 Review. No abstract available.
  • Multiple Sclerosis Agents.
    [No authors listed] [No authors listed] 2022 Sep 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Sep 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643690 Free Books & Documents. Review.
See all similar articles

MeSH terms

Substances

LinkOut - more resources